VVT Med Inc. (TSXV:VVTM)

Market Cap	16.76M
Revenue (ttm)	156.00K +173.2%
Net Income	-4.38M
EPS	-0.95
Shares Out	67.03M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,000
Average Volume	6,477
Open	0.2100
Previous Close	0.2000
Day's Range	0.2000 - 0.3000
52-Week Range	0.1500 - 0.5600
Beta	n/a
RSI	50.36
Earnings Date	May 21, 2026

About VVT Med

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P – 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider veins. The company was founded in 2004 and is based in Kfar Saba, Israel.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VVTM

Financial Performance

Financial numbers in USD